UNITED LAB(03933) Key Financial Indicators

Quotes

Detailed Quotes

Company Overview

Company Profile Company Executives

Financial Analysis

Main Composition Key Indicators Financial Statement

Multi-dimentional Analyses

Company Valuation Capital Tracking Short Selling Data

YOY

Do not show

Hide blank lines

(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30

Per Share IndicaTor

Operating Cash Flow Per Share

1.53% 1.0286 37.21% 0.5652 -17.38% 1.0131 -25.75% 0.4119

Cash Flow Per Share

299.63% 0.223 737.2% 0.3452 -109.73% -0.1117 -107.46% -0.0542

Operating Income Per Share

14.25% 6.4705 18.51% 3.0816 -0.88% 5.6635 -8.3% 2.6002

Net Asset Per Share

12% 6.2285 25.36% 5.9361 22.43% 5.5611 8.11% 4.7354

Basic Earning Per Share

38.86% 0.6568 210.53% 0.4069 8.25% 0.473 -36.14% 0.131

Diluted Earning Per Share

38.86% 0.6568 210.53% 0.4069 8.25% 0.473 -36.14% 0.131

Profitability

Gross Profit Ratio

0.02% 43.397% 6.33% 44.413% 0.56% 43.388% -0.74% 41.769%

Operating Profit Ratio

-17.16% 13.015% 1.73% 15.990% 6.97% 15.711% 48.72% 15.718%

Net Profit Ratio

27.64% 10.198% 180.9% 13.236% 4.49% 7.990% -34.87% 4.712%

Earning Before Tax Ratio

23.23% 12.394% 102.14% 15.304% 0.29% 10.058% -8.05% 7.571%

ROE

18.13% 11.160% 155.47% 7.078% -4.72% 9.447% -41.59% 2.770%

ROA

35.31% 6.402% 212.16% 4.067% 13.04% 4.732% -34.06% 1.303%

Yield Quality

Operating Profit To Total Profits

-32.77% 105.008% -49.67% 104.481% 6.66% 156.202% 61.74% 207.612%

Tax To Total Profits

13.84% -17.716% 64.22% -13.512% 13.43% -20.561% -211.39% -37.761%

Operating Cash To Total Revenue

-11.13% 15.897% 15.78% 18.342% -16.65% 17.888% -19.03% 15.842%

Capital Structure

Debt Assets Ratio

0.85% 42.809% -11.49% 42.652% -26.18% 42.449% -17.78% 48.191%

Equity Multipler

0.65% 1.7484 -9.66% 1.7436 -26.18% 1.7372 -20.11% 1.9302

Debt Equity Ratio

1.49% 74.853% -20.04% 74.373% -45.49% 73.758% -34.31% 93.016%

Current Assets To tatal Assets

11.25% 61.149% 9.02% 59.359% -0.96% 54.966% 9.73% 54.450%

Non Current Assets To Total Assets

-13.73% 38.851% -10.78% 40.641% 1.2% 45.034% -9.58% 45.550%

Current Liabilities To tatal Liabilities

22.18% 93.478% 29.53% 83.502% 6.94% 76.511% -28% 64.465%

Non Current Liabilities To Total Liabilities

-72.23% 6.522% -53.57% 16.498% -17.46% 23.489% 239.61% 35.535%

Solvency

Current Ratio

-9.71% 1.5281 -4.91% 1.6667 25.45% 1.6924 85.34% 1.7527

Quick Ratio

-12.66% 1.2214 -3.6% 1.3738 26.54% 1.3985 88.65% 1.4252

Operating Profit To Current Liabilities

-31.86% 0.1932 -7.13% 0.1337 48.6% 0.2836 166.71% 0.1439

Operrating Cash Flow To Current Liabilities

-26.9% 0.236 5.69% 0.1533 15.79% 0.3229 45.22% 0.1451

Share Equity Without Minority Interest To Total Liabilities

-1.48% 1.336 25.08% 1.3447 83.5% 1.3561 52.23% 1.0751

Operating Cash Flow To Total Liabilities

-10.69% 0.2206 36.9% 0.128 23.83% 0.2471 4.55% 0.0935

Operating Profit To Total Liabilities

-16.75% 0.1806 20.29% 0.1116 58.92% 0.217 92.03% 0.0928

Operating Capacity

Current Assets Turnover（T）

0.99% 1.0796 7.03% 0.5381 -0.8% 1.069 -12.03% 0.5028

Fixed Assets Turnover（T）

12.07% 1.6427 14% 0.7868 12.23% 1.4658 8.05% 0.6902

Total Assets Turnover（T）

6.48% 0.6287 11.41% 0.308 7.86% 0.5905 1.25% 0.2765

Growth Ability

Operating Revenue GR 3Y

39.19% 38.457% 16.06% 26.072% -15.4% 27.629% -31.32% 22.465%

Gross Income GR 3Y

61.53% 36.059% 35.47% 24.015% -16.06% 22.323% -37.28% 17.727%

Operating Profit GR 3Y

-73.49% 66.621% -78.65% 39.965% -49.88% 251.323% 69.97% 187.172%

EBT GR 3Y

-94.68% 62.348% 277.28% 390.465% 65.4% 1170.942% -63.24% 103.494%

Net Profit GR 3Y

-92.64% 55.289% 675.57% 594.134% 127.62% 751.471% -96.71% 76.606%

Net Profit Attributable To The Parent Company GR 3Y

-92.7% 55.056% 673.34% 592.420% 128.38% 753.987% -96.71% 76.606%

Total Assets GR 3Y

302.68% 19.575% 526.88% 11.428% -5.45% 4.861% -328.6% -2.677%

Share Equity Without Minority Interest GR 3Y

11.65% 63.124% 82.81% 66.634% 129.03% 56.538% 285.26% 36.450%

Equity GR 3Y

11.71% 63.114% 82.78% 66.625% 128.88% 56.500% 285.26% 36.450%

Total Liabilities GR 3Y

56.96% -11.857% 10.55% -22.909% -377.13% -27.550% -545.83% -25.610%

Basic Earning Per Share GR 3Y

-94.51% 37.677% 637.62% 512.651% 108.91% 686.064% -96.99% 69.501%

Net Assets Per Share GR 3Y

19.42% 45.828% 115.54% 48.465% 61.87% 38.377% 161.35% 22.486%

Other Indicators

Currency Unit

HKDHKDHKDHKD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

Company Overview More

Federal Pharmaceutical International Holdings Co., Ltd. is an investment holding company, mainly engaged in the sale of intermediate products, API and preparation products. The company operates through three business units. The intermediate department is engaged in the business of selling intermediate products. The API Department is engaged in the business of selling APIs. The preparation products Department is engaged in the sales of antibiotic preparation products, non-antibiotic preparation products and hollow capsules. The company, through its subsidiaries, is also engaged in the manufacture and sale of organic fertilizers.

CEO： Haishan Cai

Market： Hong Kong motherboard

Hot List

TradeSearchNews

SymbolLatest price%Chg